Clinical Trials Logo

Filter by:
NCT ID: NCT03017235 Completed - Bowel Preparation Clinical Trials

A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy

Start date: February 20, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution with PREPOPIK® for colon cleansing in adult subjects undergoing colonoscopy.

NCT ID: NCT03016728 Completed - Clinical trials for Adolescent and Young Adult Cancer Survivors

Physical Activity for Adolescent and Young Adult Cancer Survivors

Start date: September 11, 2017
Phase: N/A
Study type: Interventional

More adolescents and young adults are surviving cancer than ever before. Many endure negative effects related to their cancer and its treatment, which reduces their quality of life and functioning. Physical activity is one strategy that has been shown to promote quality of life amongst cancer survivors. However, very little research has focused on adolescent and young adult cancer survivors. Therefore, the purpose of this pilot randomized controlled trial is to explore the feasibility, safety, and potential benefits of a 12-week home-based physical activity intervention in adolescent and young adult cancer survivors.

NCT ID: NCT03016325 Completed - Heart Failure Clinical Trials

Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure

STANDUP AHF
Start date: January 13, 2017
Phase: Phase 2
Study type: Interventional

A Study to Evaluate Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of HNO Donor in Hospitalized Patients with Heart Failure and Impaired Systolic Function

NCT ID: NCT03016312 Completed - Clinical trials for Prostatic Neoplasms, Castration-Resistant

A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

IMbassador250
Start date: January 10, 2017
Phase: Phase 3
Study type: Interventional

This Phase III, multicenter, randomized, open-label study will evaluate the safety and efficacy of atezolizumab (anti-programmed death-ligand 1 [anti-PD-L1] antibody) in combination with enzalutamide compared with enzalutamide alone in participants with mCRPC after failure of an androgen synthesis inhibitor (e.g., abiraterone) and failure of, ineligibility for, or refusal of a taxane regimen. Participants will be randomized to one of the two treatment arms (atezolizumab in combination with enzalutamide, and enzalutamide alone) in a 1:1 ratio (experimental to control arm) in global randomized phase. Participants will receive treatment until investigator-assessed confirmed radiographic disease progression per Prostate Cancer Working Group 3 (PCWG3) criteria or unacceptable toxicity.

NCT ID: NCT03016169 Completed - Clinical trials for Aortic Valve Disease

Trifecta™ GT Post Market Clinical Follow-up

Start date: March 9, 2017
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the safety and performance of the Trifecta™ GT (Glide Technology) valve through 5 year follow-up in a prospective, multi-center, real-world setting. This study is intended to satisfy post-market clinical follow-up requirements of CE Mark in Europe.

NCT ID: NCT03015363 Completed - Hypertension Clinical Trials

Clinical Calibration & Validation of a Next-Generation Blood Pressure Monitor for Patient Management

CCV
Start date: November 2013
Phase:
Study type: Observational

The objective of the Cloud DX Pulsewave Health Monitor study is to prospectively calibrate and validate a novel, non-invasive wrist cuff blood pressure device against the gold standard for hemodynamic monitoring (intra-arterial pressure) in voluntarily consented patient participants who are scheduled for an elective cardiac catheterization procedure for clinically valid reasons.

NCT ID: NCT03014635 Completed - Clinical trials for Glabellar Frown Lines

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Start date: December 5, 2016
Phase: Phase 3
Study type: Interventional

This is a safety and efficacy study of DaxibotulinumtoxinA for Injection to treat moderate to severe frown lines.

NCT ID: NCT03013543 Completed - Obesity Clinical Trials

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Start date: February 10, 2017
Phase: Phase 2
Study type: Interventional

The purpose of the study was to determine the effect of setmelanotide (RM-493) on weight, hunger assessments, and other factors in participants with rare genetic disorders of obesity.

NCT ID: NCT03013088 Completed - Clinical trials for Peripheral Artery Disease

Soundbite Crossing System Peripheral First in Man

Start date: December 2016
Phase: N/A
Study type: Interventional

This is a clinical study aimed at demonstrating the safety and product performance of the SoundBite Crossing System. The study shall demonstrate that the SoundBite Crossing System can facilitate passage of a standard guidewire through a Chronic Total Occlusion (CTO) located in the lower extremity arteries without major adverse events related to SoundBite device utilization.

NCT ID: NCT03012841 Completed - Atrial Fibrillation Clinical Trials

STOP Persistent AF

Start date: March 2, 2017
Phase: N/A
Study type: Interventional

To demonstrate safety and effectiveness of the Arctic Front Advance™ and Freezor MAX® Cardiac CryoAblation Catheters for the treatment of drug refractory recurrent symptomatic persistent atrial fibrillation (AF).